Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole, Minocycline or Aspirin as add-on to antipsychotics in schizophrenia
2010-023982-23Phase 3Completed
- Sponsor
- Stanley Medical Research Institute
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pramipexole, minocycline and aspirin in schizophrenia and schizoaffective disorder (4 arms), sponsored by Stanley Medical Research Institute. Primary endpoint: PANSS total score at end of trial. Started Nov 2010; status: completed.
02
Drugs
pramipexoleminocyclineaspirin
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on 2010-023982-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023982-23.